L2079
SEREXIS 180, defined FBS replacement
SEREXIS™ 180 is a defined replacement for fetal bovine serum (FBS) in cell culture. It was developed for researchers who want to keep the performance they rely on from FBS, while moving toward a more controlled, reproducible, and FBS-free system. For cell types with increased lipid or fatty acid requirements, SEREXIS™ 180 can be complemented with Lipid Mix 18
SEREXIS™ 180 is designed for direct substitution at standard serum concentrations and can be integrated into established FBS-based workflows without major protocol changes. It supports reliable cell growth, adherence, proliferation, viability, and morphology across multiple cell types, including A549, HeLa, MDCK, Vero, primary immune cells, keratinocytes, and fibroblasts.